nodes	percent_of_prediction	percent_of_DWPC	metapath
Buspirone—CYP3A5—Teniposide—lymphatic system cancer	0.138	0.201	CbGbCtD
Buspirone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0883	0.129	CbGbCtD
Buspirone—CYP3A7—Vincristine—lymphatic system cancer	0.0883	0.129	CbGbCtD
Buspirone—CYP3A5—Vincristine—lymphatic system cancer	0.0663	0.0969	CbGbCtD
Buspirone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0627	0.0916	CbGbCtD
Buspirone—CYP3A4—Cytarabine—lymphatic system cancer	0.0545	0.0797	CbGbCtD
Buspirone—CYP3A4—Teniposide—lymphatic system cancer	0.0537	0.0785	CbGbCtD
Buspirone—ABCB1—Vincristine—lymphatic system cancer	0.0431	0.063	CbGbCtD
Buspirone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0375	0.0549	CbGbCtD
Buspirone—ABCB1—Methotrexate—lymphatic system cancer	0.0261	0.0382	CbGbCtD
Buspirone—CYP3A4—Vincristine—lymphatic system cancer	0.0258	0.0378	CbGbCtD
Buspirone—Weight increased—Mitoxantrone—lymphatic system cancer	0.000916	0.0029	CcSEcCtD
Buspirone—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00091	0.00288	CcSEcCtD
Buspirone—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000908	0.00287	CcSEcCtD
Buspirone—Myocardial infarction—Vincristine—lymphatic system cancer	0.000903	0.00286	CcSEcCtD
Buspirone—Feeling abnormal—Teniposide—lymphatic system cancer	0.000902	0.00285	CcSEcCtD
Buspirone—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000897	0.00284	CcSEcCtD
Buspirone—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.000891	0.00282	CcSEcCtD
Buspirone—Chills—Bleomycin—lymphatic system cancer	0.000891	0.00282	CcSEcCtD
Buspirone—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000884	0.0028	CcSEcCtD
Buspirone—Sweating—Vincristine—lymphatic system cancer	0.000883	0.0028	CcSEcCtD
Buspirone—Nausea—Mechlorethamine—lymphatic system cancer	0.000882	0.00279	CcSEcCtD
Buspirone—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000879	0.00278	CcSEcCtD
Buspirone—Alopecia—Bleomycin—lymphatic system cancer	0.000877	0.00278	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000876	0.00277	CcSEcCtD
Buspirone—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000872	0.00276	CcSEcCtD
Buspirone—Haemoglobin—Carmustine—lymphatic system cancer	0.000871	0.00276	CcSEcCtD
Buspirone—Urticaria—Teniposide—lymphatic system cancer	0.000869	0.00275	CcSEcCtD
Buspirone—Haemorrhage—Carmustine—lymphatic system cancer	0.000866	0.00274	CcSEcCtD
Buspirone—Body temperature increased—Teniposide—lymphatic system cancer	0.000865	0.00274	CcSEcCtD
Buspirone—Erythema—Bleomycin—lymphatic system cancer	0.000864	0.00273	CcSEcCtD
Buspirone—Paraesthesia—Fludarabine—lymphatic system cancer	0.000864	0.00273	CcSEcCtD
Buspirone—Hallucination—Carmustine—lymphatic system cancer	0.000862	0.00273	CcSEcCtD
Buspirone—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000862	0.00273	CcSEcCtD
Buspirone—Sweating—Mitoxantrone—lymphatic system cancer	0.00086	0.00272	CcSEcCtD
Buspirone—Dyspnoea—Fludarabine—lymphatic system cancer	0.000857	0.00271	CcSEcCtD
Buspirone—Dyspepsia—Fludarabine—lymphatic system cancer	0.000847	0.00268	CcSEcCtD
Buspirone—Dysarthria—Methotrexate—lymphatic system cancer	0.000845	0.00267	CcSEcCtD
Buspirone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000836	0.00265	CcSEcCtD
Buspirone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00083	0.00263	CcSEcCtD
Buspirone—Fatigue—Fludarabine—lymphatic system cancer	0.000829	0.00262	CcSEcCtD
Buspirone—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000823	0.0026	CcSEcCtD
Buspirone—Hallucination—Vincristine—lymphatic system cancer	0.000823	0.0026	CcSEcCtD
Buspirone—Pain—Fludarabine—lymphatic system cancer	0.000822	0.0026	CcSEcCtD
Buspirone—Constipation—Fludarabine—lymphatic system cancer	0.000822	0.0026	CcSEcCtD
Buspirone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00082	0.0026	CcSEcCtD
Buspirone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00081	0.00256	CcSEcCtD
Buspirone—Hypersensitivity—Teniposide—lymphatic system cancer	0.000806	0.00255	CcSEcCtD
Buspirone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000805	0.00255	CcSEcCtD
Buspirone—Flushing—Carmustine—lymphatic system cancer	0.000804	0.00254	CcSEcCtD
Buspirone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000802	0.00254	CcSEcCtD
Buspirone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000793	0.00251	CcSEcCtD
Buspirone—Asthenia—Teniposide—lymphatic system cancer	0.000785	0.00248	CcSEcCtD
Buspirone—Malaise—Bleomycin—lymphatic system cancer	0.000779	0.00247	CcSEcCtD
Buspirone—Pruritus—Teniposide—lymphatic system cancer	0.000774	0.00245	CcSEcCtD
Buspirone—Leukopenia—Bleomycin—lymphatic system cancer	0.000773	0.00245	CcSEcCtD
Buspirone—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.000772	0.00244	CcSEcCtD
Buspirone—Alopecia—Carmustine—lymphatic system cancer	0.000766	0.00242	CcSEcCtD
Buspirone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00076	0.00241	CcSEcCtD
Buspirone—Erythema—Carmustine—lymphatic system cancer	0.000754	0.00239	CcSEcCtD
Buspirone—Diarrhoea—Teniposide—lymphatic system cancer	0.000749	0.00237	CcSEcCtD
Buspirone—Chest pain—Bleomycin—lymphatic system cancer	0.000736	0.00233	CcSEcCtD
Buspirone—Myalgia—Bleomycin—lymphatic system cancer	0.000736	0.00233	CcSEcCtD
Buspirone—Alopecia—Vincristine—lymphatic system cancer	0.000731	0.00231	CcSEcCtD
Buspirone—Discomfort—Bleomycin—lymphatic system cancer	0.000727	0.0023	CcSEcCtD
Buspirone—Chills—Mitoxantrone—lymphatic system cancer	0.000723	0.00229	CcSEcCtD
Buspirone—Ecchymosis—Methotrexate—lymphatic system cancer	0.000722	0.00229	CcSEcCtD
Buspirone—Alopecia—Mitoxantrone—lymphatic system cancer	0.000712	0.00225	CcSEcCtD
Buspirone—Confusional state—Bleomycin—lymphatic system cancer	0.000711	0.00225	CcSEcCtD
Buspirone—Vision blurred—Carmustine—lymphatic system cancer	0.000711	0.00225	CcSEcCtD
Buspirone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000709	0.00224	CcSEcCtD
Buspirone—Tremor—Carmustine—lymphatic system cancer	0.000707	0.00224	CcSEcCtD
Buspirone—Oedema—Bleomycin—lymphatic system cancer	0.000705	0.00223	CcSEcCtD
Buspirone—Erythema—Mitoxantrone—lymphatic system cancer	0.000701	0.00222	CcSEcCtD
Buspirone—Vomiting—Teniposide—lymphatic system cancer	0.000696	0.0022	CcSEcCtD
Buspirone—Agitation—Carmustine—lymphatic system cancer	0.000693	0.00219	CcSEcCtD
Buspirone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00069	0.00219	CcSEcCtD
Buspirone—Asthenia—Fludarabine—lymphatic system cancer	0.00069	0.00218	CcSEcCtD
Buspirone—Rash—Teniposide—lymphatic system cancer	0.00069	0.00218	CcSEcCtD
Buspirone—Dermatitis—Teniposide—lymphatic system cancer	0.000689	0.00218	CcSEcCtD
Buspirone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000687	0.00217	CcSEcCtD
Buspirone—Headache—Teniposide—lymphatic system cancer	0.000686	0.00217	CcSEcCtD
Buspirone—Pruritus—Fludarabine—lymphatic system cancer	0.00068	0.00215	CcSEcCtD
Buspirone—Leukopenia—Carmustine—lymphatic system cancer	0.000675	0.00214	CcSEcCtD
Buspirone—Anorexia—Bleomycin—lymphatic system cancer	0.000672	0.00213	CcSEcCtD
Buspirone—Agitation—Vincristine—lymphatic system cancer	0.000662	0.00209	CcSEcCtD
Buspirone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000661	0.00209	CcSEcCtD
Buspirone—Hypotension—Bleomycin—lymphatic system cancer	0.000659	0.00209	CcSEcCtD
Buspirone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000658	0.00208	CcSEcCtD
Buspirone—Convulsion—Carmustine—lymphatic system cancer	0.000653	0.00207	CcSEcCtD
Buspirone—Hypertension—Carmustine—lymphatic system cancer	0.000651	0.00206	CcSEcCtD
Buspirone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000651	0.00206	CcSEcCtD
Buspirone—Nausea—Teniposide—lymphatic system cancer	0.00065	0.00206	CcSEcCtD
Buspirone—Vertigo—Vincristine—lymphatic system cancer	0.000647	0.00205	CcSEcCtD
Buspirone—Leukopenia—Vincristine—lymphatic system cancer	0.000644	0.00204	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000642	0.00203	CcSEcCtD
Buspirone—Myalgia—Carmustine—lymphatic system cancer	0.000642	0.00203	CcSEcCtD
Buspirone—Chest pain—Carmustine—lymphatic system cancer	0.000642	0.00203	CcSEcCtD
Buspirone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000633	0.002	CcSEcCtD
Buspirone—Malaise—Mitoxantrone—lymphatic system cancer	0.000632	0.002	CcSEcCtD
Buspirone—Dyspnoea—Bleomycin—lymphatic system cancer	0.000629	0.00199	CcSEcCtD
Buspirone—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000628	0.00199	CcSEcCtD
Buspirone—Convulsion—Vincristine—lymphatic system cancer	0.000624	0.00197	CcSEcCtD
Buspirone—Hypertension—Vincristine—lymphatic system cancer	0.000622	0.00197	CcSEcCtD
Buspirone—Confusional state—Carmustine—lymphatic system cancer	0.000621	0.00196	CcSEcCtD
Buspirone—Oedema—Carmustine—lymphatic system cancer	0.000616	0.00195	CcSEcCtD
Buspirone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000613	0.00194	CcSEcCtD
Buspirone—Myalgia—Vincristine—lymphatic system cancer	0.000613	0.00194	CcSEcCtD
Buspirone—Vomiting—Fludarabine—lymphatic system cancer	0.000611	0.00194	CcSEcCtD
Buspirone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000607	0.00192	CcSEcCtD
Buspirone—Rash—Fludarabine—lymphatic system cancer	0.000606	0.00192	CcSEcCtD
Buspirone—Dermatitis—Fludarabine—lymphatic system cancer	0.000606	0.00192	CcSEcCtD
Buspirone—Hypertension—Mitoxantrone—lymphatic system cancer	0.000605	0.00192	CcSEcCtD
Buspirone—Pain—Bleomycin—lymphatic system cancer	0.000603	0.00191	CcSEcCtD
Buspirone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000603	0.00191	CcSEcCtD
Buspirone—Headache—Fludarabine—lymphatic system cancer	0.000602	0.00191	CcSEcCtD
Buspirone—Tachycardia—Carmustine—lymphatic system cancer	0.000601	0.0019	CcSEcCtD
Buspirone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000597	0.00189	CcSEcCtD
Buspirone—Chest pain—Mitoxantrone—lymphatic system cancer	0.000597	0.00189	CcSEcCtD
Buspirone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000597	0.00189	CcSEcCtD
Buspirone—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000592	0.00187	CcSEcCtD
Buspirone—Discomfort—Mitoxantrone—lymphatic system cancer	0.00059	0.00187	CcSEcCtD
Buspirone—Oedema—Vincristine—lymphatic system cancer	0.000588	0.00186	CcSEcCtD
Buspirone—Anorexia—Carmustine—lymphatic system cancer	0.000587	0.00186	CcSEcCtD
Buspirone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000581	0.00184	CcSEcCtD
Buspirone—Confusional state—Mitoxantrone—lymphatic system cancer	0.000577	0.00183	CcSEcCtD
Buspirone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000575	0.00182	CcSEcCtD
Buspirone—Hypotension—Carmustine—lymphatic system cancer	0.000575	0.00182	CcSEcCtD
Buspirone—Oedema—Mitoxantrone—lymphatic system cancer	0.000572	0.00181	CcSEcCtD
Buspirone—Nausea—Fludarabine—lymphatic system cancer	0.000571	0.00181	CcSEcCtD
Buspirone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000568	0.0018	CcSEcCtD
Buspirone—Shock—Mitoxantrone—lymphatic system cancer	0.000563	0.00178	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000561	0.00177	CcSEcCtD
Buspirone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00056	0.00177	CcSEcCtD
Buspirone—Urticaria—Bleomycin—lymphatic system cancer	0.00056	0.00177	CcSEcCtD
Buspirone—Anorexia—Vincristine—lymphatic system cancer	0.00056	0.00177	CcSEcCtD
Buspirone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000558	0.00177	CcSEcCtD
Buspirone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000557	0.00176	CcSEcCtD
Buspirone—Insomnia—Carmustine—lymphatic system cancer	0.000557	0.00176	CcSEcCtD
Buspirone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000553	0.00175	CcSEcCtD
Buspirone—Paraesthesia—Carmustine—lymphatic system cancer	0.000553	0.00175	CcSEcCtD
Buspirone—Mood swings—Methotrexate—lymphatic system cancer	0.00055	0.00174	CcSEcCtD
Buspirone—Hypotension—Vincristine—lymphatic system cancer	0.000549	0.00174	CcSEcCtD
Buspirone—Dyspnoea—Carmustine—lymphatic system cancer	0.000549	0.00174	CcSEcCtD
Buspirone—Somnolence—Carmustine—lymphatic system cancer	0.000547	0.00173	CcSEcCtD
Buspirone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000545	0.00173	CcSEcCtD
Buspirone—Ataxia—Methotrexate—lymphatic system cancer	0.000545	0.00173	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000535	0.00169	CcSEcCtD
Buspirone—Decreased appetite—Carmustine—lymphatic system cancer	0.000535	0.00169	CcSEcCtD
Buspirone—Hypotension—Mitoxantrone—lymphatic system cancer	0.000535	0.00169	CcSEcCtD
Buspirone—Insomnia—Vincristine—lymphatic system cancer	0.000531	0.00168	CcSEcCtD
Buspirone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000531	0.00168	CcSEcCtD
Buspirone—Paraesthesia—Vincristine—lymphatic system cancer	0.000528	0.00167	CcSEcCtD
Buspirone—Pain—Carmustine—lymphatic system cancer	0.000526	0.00167	CcSEcCtD
Buspirone—Constipation—Carmustine—lymphatic system cancer	0.000526	0.00167	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000521	0.00165	CcSEcCtD
Buspirone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00052	0.00164	CcSEcCtD
Buspirone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000514	0.00163	CcSEcCtD
Buspirone—Decreased appetite—Vincristine—lymphatic system cancer	0.000511	0.00162	CcSEcCtD
Buspirone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00051	0.00161	CcSEcCtD
Buspirone—Somnolence—Mitoxantrone—lymphatic system cancer	0.000509	0.00161	CcSEcCtD
Buspirone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000507	0.00161	CcSEcCtD
Buspirone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000507	0.00161	CcSEcCtD
Buspirone—Fatigue—Vincristine—lymphatic system cancer	0.000507	0.0016	CcSEcCtD
Buspirone—Asthenia—Bleomycin—lymphatic system cancer	0.000506	0.0016	CcSEcCtD
Buspirone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000504	0.00159	CcSEcCtD
Buspirone—Pain—Vincristine—lymphatic system cancer	0.000502	0.00159	CcSEcCtD
Buspirone—Constipation—Vincristine—lymphatic system cancer	0.000502	0.00159	CcSEcCtD
Buspirone—Pruritus—Bleomycin—lymphatic system cancer	0.000499	0.00158	CcSEcCtD
Buspirone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000497	0.00157	CcSEcCtD
Buspirone—Eosinophilia—Methotrexate—lymphatic system cancer	0.000496	0.00157	CcSEcCtD
Buspirone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000493	0.00156	CcSEcCtD
Buspirone—Pain—Mitoxantrone—lymphatic system cancer	0.000489	0.00155	CcSEcCtD
Buspirone—Constipation—Mitoxantrone—lymphatic system cancer	0.000489	0.00155	CcSEcCtD
Buspirone—Body temperature increased—Carmustine—lymphatic system cancer	0.000487	0.00154	CcSEcCtD
Buspirone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000472	0.00149	CcSEcCtD
Buspirone—Dysuria—Methotrexate—lymphatic system cancer	0.000469	0.00148	CcSEcCtD
Buspirone—Body temperature increased—Vincristine—lymphatic system cancer	0.000464	0.00147	CcSEcCtD
Buspirone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000462	0.00146	CcSEcCtD
Buspirone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000455	0.00144	CcSEcCtD
Buspirone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000453	0.00144	CcSEcCtD
Buspirone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000452	0.00143	CcSEcCtD
Buspirone—Vomiting—Bleomycin—lymphatic system cancer	0.000448	0.00142	CcSEcCtD
Buspirone—Drowsiness—Methotrexate—lymphatic system cancer	0.000447	0.00141	CcSEcCtD
Buspirone—Depression—Methotrexate—lymphatic system cancer	0.000446	0.00141	CcSEcCtD
Buspirone—Rash—Bleomycin—lymphatic system cancer	0.000445	0.00141	CcSEcCtD
Buspirone—Dermatitis—Bleomycin—lymphatic system cancer	0.000444	0.00141	CcSEcCtD
Buspirone—Asthenia—Carmustine—lymphatic system cancer	0.000442	0.0014	CcSEcCtD
Buspirone—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000435	0.00138	CcSEcCtD
Buspirone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000433	0.00137	CcSEcCtD
Buspirone—Sweating—Methotrexate—lymphatic system cancer	0.000429	0.00136	CcSEcCtD
Buspirone—Epistaxis—Methotrexate—lymphatic system cancer	0.000422	0.00133	CcSEcCtD
Buspirone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000422	0.00133	CcSEcCtD
Buspirone—Asthenia—Vincristine—lymphatic system cancer	0.000422	0.00133	CcSEcCtD
Buspirone—Diarrhoea—Carmustine—lymphatic system cancer	0.000421	0.00133	CcSEcCtD
Buspirone—Nausea—Bleomycin—lymphatic system cancer	0.000419	0.00133	CcSEcCtD
Buspirone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000411	0.0013	CcSEcCtD
Buspirone—Dizziness—Carmustine—lymphatic system cancer	0.000407	0.00129	CcSEcCtD
Buspirone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000403	0.00128	CcSEcCtD
Buspirone—Diarrhoea—Vincristine—lymphatic system cancer	0.000402	0.00127	CcSEcCtD
Buspirone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000401	0.00127	CcSEcCtD
Buspirone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000392	0.00124	CcSEcCtD
Buspirone—Vomiting—Carmustine—lymphatic system cancer	0.000391	0.00124	CcSEcCtD
Buspirone—Dizziness—Vincristine—lymphatic system cancer	0.000389	0.00123	CcSEcCtD
Buspirone—Rash—Carmustine—lymphatic system cancer	0.000388	0.00123	CcSEcCtD
Buspirone—Dermatitis—Carmustine—lymphatic system cancer	0.000388	0.00123	CcSEcCtD
Buspirone—Headache—Carmustine—lymphatic system cancer	0.000386	0.00122	CcSEcCtD
Buspirone—Tinnitus—Methotrexate—lymphatic system cancer	0.000374	0.00118	CcSEcCtD
Buspirone—Vomiting—Vincristine—lymphatic system cancer	0.000374	0.00118	CcSEcCtD
Buspirone—Rash—Vincristine—lymphatic system cancer	0.00037	0.00117	CcSEcCtD
Buspirone—Dermatitis—Vincristine—lymphatic system cancer	0.00037	0.00117	CcSEcCtD
Buspirone—Headache—Vincristine—lymphatic system cancer	0.000368	0.00116	CcSEcCtD
Buspirone—Nausea—Carmustine—lymphatic system cancer	0.000366	0.00116	CcSEcCtD
Buspirone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000364	0.00115	CcSEcCtD
Buspirone—Rash—Mitoxantrone—lymphatic system cancer	0.000361	0.00114	CcSEcCtD
Buspirone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00036	0.00114	CcSEcCtD
Buspirone—Chills—Methotrexate—lymphatic system cancer	0.00036	0.00114	CcSEcCtD
Buspirone—Headache—Mitoxantrone—lymphatic system cancer	0.000358	0.00113	CcSEcCtD
Buspirone—Alopecia—Methotrexate—lymphatic system cancer	0.000355	0.00112	CcSEcCtD
Buspirone—Erythema—Methotrexate—lymphatic system cancer	0.000349	0.00111	CcSEcCtD
Buspirone—Nausea—Vincristine—lymphatic system cancer	0.000349	0.0011	CcSEcCtD
Buspirone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000342	0.00108	CcSEcCtD
Buspirone—Nausea—Mitoxantrone—lymphatic system cancer	0.00034	0.00108	CcSEcCtD
Buspirone—Vision blurred—Methotrexate—lymphatic system cancer	0.000329	0.00104	CcSEcCtD
Buspirone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000324	0.00103	CcSEcCtD
Buspirone—Malaise—Methotrexate—lymphatic system cancer	0.000315	0.000997	CcSEcCtD
Buspirone—Vertigo—Methotrexate—lymphatic system cancer	0.000314	0.000993	CcSEcCtD
Buspirone—Leukopenia—Methotrexate—lymphatic system cancer	0.000313	0.00099	CcSEcCtD
Buspirone—Convulsion—Methotrexate—lymphatic system cancer	0.000303	0.000958	CcSEcCtD
Buspirone—Chest pain—Methotrexate—lymphatic system cancer	0.000297	0.000941	CcSEcCtD
Buspirone—Arthralgia—Methotrexate—lymphatic system cancer	0.000297	0.000941	CcSEcCtD
Buspirone—Myalgia—Methotrexate—lymphatic system cancer	0.000297	0.000941	CcSEcCtD
Buspirone—Discomfort—Methotrexate—lymphatic system cancer	0.000294	0.00093	CcSEcCtD
Buspirone—Confusional state—Methotrexate—lymphatic system cancer	0.000287	0.00091	CcSEcCtD
Buspirone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000279	0.000883	CcSEcCtD
Buspirone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000276	0.000872	CcSEcCtD
Buspirone—Anorexia—Methotrexate—lymphatic system cancer	0.000272	0.00086	CcSEcCtD
Buspirone—Hypotension—Methotrexate—lymphatic system cancer	0.000266	0.000843	CcSEcCtD
Buspirone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00026	0.000822	CcSEcCtD
Buspirone—Insomnia—Methotrexate—lymphatic system cancer	0.000258	0.000816	CcSEcCtD
Buspirone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000256	0.00081	CcSEcCtD
Buspirone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000254	0.000804	CcSEcCtD
Buspirone—Somnolence—Methotrexate—lymphatic system cancer	0.000253	0.000802	CcSEcCtD
Buspirone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000251	0.000794	CcSEcCtD
Buspirone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000248	0.000784	CcSEcCtD
Buspirone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000246	0.000779	CcSEcCtD
Buspirone—Fatigue—Methotrexate—lymphatic system cancer	0.000246	0.000778	CcSEcCtD
Buspirone—Pain—Methotrexate—lymphatic system cancer	0.000244	0.000772	CcSEcCtD
Buspirone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000235	0.000744	CcSEcCtD
Buspirone—Urticaria—Methotrexate—lymphatic system cancer	0.000226	0.000717	CcSEcCtD
Buspirone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000225	0.000713	CcSEcCtD
Buspirone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00021	0.000665	CcSEcCtD
Buspirone—Asthenia—Methotrexate—lymphatic system cancer	0.000205	0.000647	CcSEcCtD
Buspirone—Pruritus—Methotrexate—lymphatic system cancer	0.000202	0.000638	CcSEcCtD
Buspirone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000195	0.000617	CcSEcCtD
Buspirone—Dizziness—Methotrexate—lymphatic system cancer	0.000189	0.000597	CcSEcCtD
Buspirone—Vomiting—Methotrexate—lymphatic system cancer	0.000181	0.000574	CcSEcCtD
Buspirone—Rash—Methotrexate—lymphatic system cancer	0.00018	0.000569	CcSEcCtD
Buspirone—Dermatitis—Methotrexate—lymphatic system cancer	0.00018	0.000568	CcSEcCtD
Buspirone—Headache—Methotrexate—lymphatic system cancer	0.000179	0.000565	CcSEcCtD
Buspirone—Nausea—Methotrexate—lymphatic system cancer	0.000169	0.000536	CcSEcCtD
